Академический Документы
Профессиональный Документы
Культура Документы
Torello Lotti, MD
Professor of Dermatology and Venereology Florence, Italy
MELANOCYTES
Melanocytes are pigment-producing cells that originate from the dorsal portion of the closing neural tube in vertebrate embryos.
Melanoblast migration and differentiation into melanocytes is influenced by a number of signaling molecules produced by neighboring cells that interact with their their specific cell surface receptors.
Bone morphogenetic factor (BMPs) Wnt Hepatocyte growth factor (HGF) Endothelin-3 (ET-3) Stem Cell Factor (SCF), c-Kit-ligand
Wnt Family
16 different secreted glycoproteins;
Wnt
Frizzled receptor
- catenin
Induce the transcription of 3 key enzyme in melanin synthesis: Transcription of - Tyrosinase; - TRP-1; - TRP-2.
Waardenburg syndrome type 2A - different colored irises; - white forelock; - congenital cochlear deafness.
normal MITF activity is completely lost in these animals usually MITF activity is only partially lost
Endothelins Family
ET-1, ET-2, ET-3 ET-3 + EdnrB:
- required for survival, prolifeartion and migration of melanoblasts; - also affect the development of other neural crest cells. - exracutaneous symptomatology in type IV Waardenburg syndrome and in Hirschsrung syndrome.
Mutations of c-Kit or SCF: melanoblast unable to migrate to the skin and/or survive there
PIEBALDISM
Leptomeninges
MELANOBLAST
Choroid
Ciliary body
Iris
CUTANEOUS MELANOCYTES
Melanocyte density/mm2: 550-1200 (highest concentration in genitalia and face) Melanocytes syntesize melanine, stored in cyosolic organelles (melanosomes) transferred to keratinocytes through dendritic process.
MELANIZATION
The synthesis and distribution of melanin in the epidermis (pigmentation) involves several step: Transcription of proteins required to melanogenesis Melanosome biogenesis Sorting of melanogenic proteins into the melanosomes Transport of melanosomes to the tips of melanocyte dendritic cells
Melanosome Biogenesis
Unique menbrane bound organelle (modified version of lysosomes?) in which melanin biosynthesis take place.
Eumelanosomes Eumelanin
Pheomelanosomes Pheomelanin
Melanosome Biogenesis
MELANIN BIOSYNTHESIS
Two types of melanin
Dark, brown/black
Eumelanin
Light, red/yellow
Pheomelanin
Melanin provide protection against UV (280-400 nm)induced DNA damage; UV absorbed is converted into heat (less toxic form of energy).
Melanin and its intermediates can be harmful to melanocytes: ROS generation: DNA damage: melanoma
MELANOGENIC PROTEINS
Enzymes and proteins involved in melanosomal maturation
Tyrosinase: Chromosome 11
Synthesized in Endoplasmic reticulus Glycosilation in Golgi apparatus Packaged in endosomes Fuse in melanosome stage II Mutations (missense, nonsense frameshift, deletion):
Mutations:
TRP-2: chromosome 13
Mitf activity is induced by binding of SCF to c-Kit receptor and by cAMPelevating agents such MSH.
Melanocyte survival +
Cdk2
Mitf
-/+ p21
(Melanocyte proliferation)
G1 to S phase
-MSH MC1R
cAMP
transcription
Mitf
Polimorphisms within the MC1R gene are largely responsible for the different skin/hair color among different ethnic group.
UV light activates a cascade that results in elevated melanin synthesis and transport
MELANIN BIOSYNTHESIS
Dessinioti C et al.A review of genetic disorders of hypopigmentation: Lessons learned from the biology of melanocytes. Experimental Dermatology 2009; 18: 741749.
MELANOCYTE DENDRITES
Branching protoplasmatic process that interact with keratinocytes. Actin is a major structural component of dendrites; Several keratinocytesderived factors (ET-1, NGF, PGE2, -endorphin) play a role in melanocyte dendricity; Integrins also play a role in dendrite formation.
Cytophagocitosis
Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004
Hypomelanoses: Why ?
1. 2.
3. 4.
Loss or reduction of melanocytes; Reduced melanine production from melanocytes (altered tyrosinase activity, altered structure/activity of rough endoplasmic reticulum, lack of specific melanocyte receptors); Decreased melanine transfer from melanocytes to keratinocytes; Primary disorder of keratinocytes.
Hypomelanoses
Normal Albinism
Functional defect in melanine synthesis
Vitiligo
Localized loss / inactivation of melanocytes
Disorders of Melanocyte
Dessinioti C et al.A review of genetic disorders of hypopigmentation: Lessons learned from the biology of melanocytes. Experimental Dermatology 2009; 18: 741749.
Dessinioti C et al.A review of genetic disorders of hypopigmentation: Lessons learned from the biology of melanocytes. Experimental Dermatology 2009; 18: 741749.
VITILIGO ETIOPATHOGENESIS
GENETIC PREDISPOSITION Autoimmune Susceptibility Locus (AIS1) NEURAL HYPOTHESIS AUTOIMMUNE HYPOTHESIS
MELANOCYTE DESTRUCTION
Vitiligo etiopathogenesis
GENETIC PREDISPOSITION
Autoimmune Susceptibility Locus (AIS1) AUTOIMMUNE Umoral mechanism -Autoantibodies Citotoxic mechanism Cell mediated METABOLIC Hydrogen peroxide accumulation Abnormal expression of Tyrosine-Related Protein -1 OTHERS Viral hypothesis Neuronal toxicity
Autoimmune Pathogenesis
Presence of vitiligo antibodies in patients; Vitiligo is associated with several autoimmune
disease (vitiligo is a syndrome, not a disease): tyroiditis (up to 40%), diabetes type I (1-7%), autoimmune gastritis, autoimmune polyglandular syndromes, alopecia areata; Most effective therapies in inducing repigmentation have also immunosuppressive effects (i.e.corticosteroids, ultraviolet, cytotoxic drugs); Immunotherapies for melanoma often cause vitiligo patches.
Autoimmune Pathogenesis
Ongenae K et al. Evidence for an Autoimmune Pathogenesis of Vitiligo. Pigment Cell Res 16: 90100. 2003
Metabolic Pathogenesis
Altered antioxidant and scavenger mechanism Increased activity of superoxide dismutase
High levels of epidermic 7-BH4 and H2O2 Inhibition of enzyme function (phenylalanine-hydroxilase and tyrosinase) and abnormal expression of Tyrosinase Related Protein-1 (TRP-1). impaired melanine synthesis
Nordlund JJ and Lerner AB Arch Dermatol, 1982;118:5-8 Le Poole IC et Al. J Invest Dermatol, 1993;100:816-822
Bertosi KJ et Al. Eur J Dermatol 1998;8:95-97 Tobin DJ et Al. J Pathol 2000;191:407-416 Gottschalk GM, Kidson SH. Int J Dermatol. 2007;46(3):268-72
Normal Skin
Perilesional Skin
Lesional Skin
Massi D. Histopathological and ultrastructural features of vitiligo. In: Lotti T & Hercogova J (Eds.) Vitiligo Problems and solutions. Marcel Dekker Inc, New York 2004
melanocytes can persist independent of disease duration Repigmentation can always occur independent of disease duration and with non-perifollicular pattern
Imokawa Imokawa G. G. Autocrine Autocrine and and paracrine paracrine regulation regulation of of melanocytes melanocytes in in human human skin skin and and in in pigmentary pigmentary disorders. disorders. Pigment Pigment Cell Cell Res Res 2004 2004
Impaired scavenging mechanisms can lead to ROS increase and subsequent melanocyte and keratinocyte damaging;
Altered function of PAR-2 receptor can impair calcium homeostasis in keratinocytes and alter melanosome intake and processing.
The importance in mitochondria in keratinocytes from perilesional skin and the role of oxidative stress.
Prignano F, et al. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Derm Sci 2009;54:157167
mRNA for TNF- and IL-6, with an inhibitory effect on pigmentation, was increased in the epidermis from vitiligo biopsies. This could contribute to keratinocyte apoptosis, which results in reduced release of melanogenic cytokines and in melanocyte disappearance.
Moretti S, et al. Histol Histopathol 2009:24:849-857
OUR CONTRIBUTIONS
Berti S, Bellandi S, Bertelli A, Colucci R, Lotti T, Moretti S. Vitiligo in an Italian outpatient center: a clinical and serologic study of 204 patients in Tuscany. Am J Clin Dermatol. 2011;12(1):43-9. Prignano F, Ricceri F, Bianchi B, Guasti D, Bonciolini V, Lotti T, Pimpinelli N. Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin. Arch Dermatol Res. 2010 Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S. Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol. 2010;145(6):783-8. Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T, Taddei N. The involvement of Smac/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: Protective effects of curcumin and capsaicin. Antioxid Redox Signal. 2010, 1;13(9):1309-1321.
Prignano F, Pescitelli L, Becatti M, Di Gennaro P, Fiorillo C, Taddei N, Lotti T. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Derm Sci 2009;54:157167; Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T and Massi D. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 2009;24:849-857; Moretti S, Nassini R, Prignano F, Pacini A, Materazzi S, Naldini A, Simoni A, Baroni G, Pellerito S, Filippi I, Lotti T, Geppetti P and Massi D. Protease-activated receptor-2 downregulation is associated to vitiligo lesions. Pigment Cell Melanoma Res. 2009;22:335338.
Prignano F, Pescitelli L, Ricceri F, Lotti T. The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. Int J Dermatol 2008;47:10601062;
Prignano F, Betts CM, Lotti T. Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin? J Electron Microsc (Tokyo). 2008